Show simple item record

dc.contributor.editorCassidy, John W.
dc.contributor.editorTaylor, Belle
dc.date.accessioned2020-12-15T13:26:56Z
dc.date.available2020-12-15T13:26:56Z
dc.date.issued2020
dc.identifier.urihttps://library.oapen.org/handle/20.500.12657/43405
dc.description.abstractThere exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence.
dc.languageEnglish
dc.subject.classificationbic Book Industry Communication::U Computing & information technology::UY Computer science::UYQ Artificial intelligence
dc.subject.otherComputers
dc.subject.otherArtificial Intelligence
dc.subject.otherGeneral
dc.titleArtificial Intelligence in Oncology Drug Discovery and Development
dc.typebook
oapen.identifier.doihttps://doi.org/10.5772/intechopen.88376
oapen.relation.isPublishedBy09f6769d-48ed-467d-b150-4cf2680656a1
oapen.relation.isFundedByb818ba9d-2dd9-4fd7-a364-7f305aef7ee9
oapen.relation.isbn9781789858983
oapen.collectionKnowledge Unlatched (KU)
oapen.imprintIntechOpen
oapen.identifierhttps://openresearchlibrary.org/viewer/e7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c
oapen.identifier.isbn9781789858983
grantor.numbere7b3ced1-1aa0-4c44-9f10-c6bdd14cdc2c


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record